THE TGA has issued a recall order
for Aspen Pharma’s Serenace 0.5mg
tablets (containing haloperidol)
batch number BJ431.
The recall is being conducted
because the manufacturer has
received reports of tablets from
the affected batch with black spots
identified as penicillium species.
The order has been classified as
Class I meaning that the defects
are potentially life-threatening or
could cause a serious risk to health.
Patients are being advised not to
use the affected batch, but to
return it to their local pharmacy
and arrange for a replacement.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Sep 12
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.